Jose Manuel C. V.
- Country
- Spain
- Department
- Hematology
Research Overview
- Evaluation of Fitusiran for Bleed Prevention in Patients with Severe Hemophilia A Previously Treated with Emicizumab
- Pharmacokinetic Evaluation of Efanesoctocog Alfa Versus Other Extended Half-Life Recombinant Factor VIII Products in Severe Haemophilia A Patients
- Phase 3 Trial of VMX-C001 Versus Usual Care in Patients on Factor Xa DOACs Requiring Urgent High-Bleeding-Risk Surgery or Invasive Procedures
Data & Insights
Has run more than one trial at 29 of 141 partner sites.
Specializations
Hematological Disorders
Specializes in the treatment of hemophilia conditions, with particular focus on investigating novel therapies for both hemophilia A and B. Has extensive experience in evaluating treatments for joint health management and bleeding prevention in hemophilia patients.
- Factor replacement therapies
- Joint health assessment
- Prophylactic treatments
Hepatic and Pancreatic Disease
Conducts research in various liver and pancreatic conditions, including acute pancreatitis, non-alcoholic steatohepatitis, and primary sclerosing cholangitis. Investigates innovative therapeutic approaches for both acute and chronic conditions.
- Pancreatitis management
- Liver fibrosis treatment
- Biliary tract disorders
Oncology
Focuses on advanced cancer treatments, particularly in gastrointestinal stromal tumors, metastatic hepatocellular carcinoma, and colorectal cancer. Specializes in evaluating targeted therapies and immunotherapy approaches.
- Targeted molecular therapies
- Metastatic disease management
- Combination treatment strategies
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.